{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-035700","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2023-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.914019+00:00","generated_at":"2026-06-10T04:50:14.857476+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sigyn Therapeutics discloses PCT patent filing for chemo delivery enhancement system","bullets":["PCT application entitled 'SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY' submitted.","Technologies ChemoPrep and ChemoPure aim to increase tumor-site drug delivery and reduce off-target toxicity.","PCT allows simultaneous patent protection in over 150 countries; related US provisional previously filed.","Company plans first-in-human studies for Sigyn Therapy; candidate indications include sepsis and pneumonia.","Reduced chemo dosing may alleviate nationwide drug shortages, per the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-035700","json":"https://secwatch.observer/filing/0001493152-23-035700.json","markdown":"https://secwatch.observer/filing/0001493152-23-035700.md","text":"https://secwatch.observer/filing/0001493152-23-035700.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223035700/0001493152-23-035700-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223035700/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:50:14.857476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}